FDA approves SenTiva nerve stimulation device for epilepsy therapy

London-based medical device manufacturer LivaNova has announced FDA approval of its most recent Vagus Nerve Stimulation Therapy (VNS Therapy) System, which will be the smallest and lightest responsive therapy available for drug-resistant epilepsy patients aged four years and older.
Source: mobihealthnews - Category: Information Technology Source Type: news